Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE835.250.05 (+0.01 %)
PREV CLOSE () 835.20
OPEN PRICE () 835.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26
TODAY'S LOW / HIGH ()835.20 836.00
52 WK LOW / HIGH () 736998.95
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1982

Management Info :

Sanjay Patel - Chairman Rajendra R Shah - Managing Director

Registered Office :

Address : 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone : 022 66372841 / 22015441

Registrar's Details : MUFG Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
Listing : BSE, OTCEI
NEWS
05Nov Mercury Laboratories informs about bo
Pursuant to Regulation 29 of the Securities and Exchange Board of India..
04Oct Mercury Laboratories informs about 10
Mercury Laboratories has informed that the Investor Education and Protec..
25Sep Mercury Laboratories informs about clo
Mercury Laboratories has informed that pursuant to Securities and Exchan..
19Jul Mercury Laboratories informs about pre
Mercury Laboratories has informed that it enclosed newspaper copies of p..
07Jul Mercury Laboratories informs about com
Mercury Laboratories has enclosed a certificate under regulation 74(5) o..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit16.4431.4500000000001
Gross Profit 19.24 46.6100000000001
Operating Profit 29.1980.8500000000001
Net Sales 190.09751.01
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 16500.00 (2.63%)
M.Cap ( in Cr)
21169.32
CORONA Remedies (BSE)
 1437.20 (35.33%)
M.Cap ( in Cr)
8789.93
Procter&Gamble Healt (BSE)
 5663.25 (1.51%)
M.Cap ( in Cr)
9400.65
Fredun Pharma (BSE)
 1660.40 (5.00%)
M.Cap ( in Cr)
783.98
RPG Life Sciences (BSE)
 2375.00 (2.90%)
M.Cap ( in Cr)
3928.02
Shareholding Pattern
PROMOTERS 73.66%
NON-INSTITUTION 26.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX85213.36-54.30 (-0.06%)
NIFTY26027.30-19.65 (-0.08%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI